“…Among groups of breeds, racehorses, mostly Thoroughbreds are particularly at risk of developing AH resistances due to frequent AH treatments with little or no parasite surveillance ( Comer et al, 2006 ; Robert et al, 2015 ). In this equine population, the resistance of strongylids to ML (IVM and/or MOX) has already been reported in the USA ( Nielsen et al, 2020 ), Australia ( Abbas et al, 2021 , 2024 and the UK ( Bull et al, 2023 ).…”